Vera Therapeutics VERA EPS (Diluted)

EPS (Diluted) at other companies

Vertex PharmaceuticalsVRTX

$4.31+8.0%

Travere Therapeutics, Inc.TVTX

-$0.40+14.9%

Aurinia PharmaceuticalsAUPH

$0.28+75.0%

Climb Bio, Inc.CLYM

-$0.20+35.5%

Jade BiosciencesJBIO

-$0.57+95.3%

Viridian Therapeutics, Inc.VRDN

-$1.15-5.5%

FAQ

What is Vera Therapeutics's EPS (diluted)?

Vera Therapeutics (VERA) reported EPS (diluted) of -$1.69 in Q1 2026.

How has Vera Therapeutics's EPS (diluted) changed year-over-year?

Vera Therapeutics's EPS (diluted) decreased by 108.6% year-over-year, from -$0.81 to -$1.69.

What is the long-term trend for Vera Therapeutics's EPS (diluted)?

Over 4 years (2021 to 2025), Vera Therapeutics's EPS (diluted) has grown at a -23.9% compound annual growth rate (CAGR), from -$13.89 to -$4.66.

What does EPS (diluted) mean?

Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.